36
Views
1
CrossRef citations to date
0
Altmetric
Perspective

Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation

Pages 663-672 | Published online: 10 Jan 2014

References

  • Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation114, 119–125 (2006).
  • Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med.347, 1825–1833 (2002).
  • Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med.347, 1834–1840 (2002).
  • Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation109, 1509–1513 (2004).
  • Roy D, Talajic M, Dorian P et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N. Engl. J. Med.342, 913–920 (2000).
  • AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J. Am. Coll. Cardiol.42, 20–29 (2003).
  • Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am. J. Cardiol.76, 47–50 (1995).
  • Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation114, e257–e354 (2006).
  • Steinberg JS, Sadaniantz A, Kron J et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation109, 1973–1980 (2004).
  • Gillis AM, Wyse DG, Connolly SJ et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation99, 2553–2558 (1999).
  • Gillis AM, Connolly SJ, Lacombe P et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators. Circulation102, 736–741 (2000).
  • Knight BP, Gersh BJ, Carlson MD et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation111, 240–243 (2005).
  • Swerdlow CD, Schwartzman D, Hoyt R, Bailin SJ, Koehler JL, Warman EN. Determinants of first-shock success for atrial implantable cardioverter defibrillators. J. Cardiovasc. Electrophysiol.13, 347–354 (2002).
  • Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med.339, 659–666 (1998).
  • Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation101, 194–199 (2000).
  • Lazar S, Dixit S, Marchlinski FE, Callans DJ, Gerstenfeld EP. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation110, 3181–3186 (2004).
  • Sanders P, Berenfeld O, Hocini M et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation112, 789–797 (2005).
  • Oral H, Knight BP, Tada H et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation105, 1077–1081 (2002).
  • Haissaguerre M, Hocini M, Sanders P et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol.16, 1138–1147 (2005).
  • Swartz J, Perrersels G, Silvers J. A catheter based curative approach to atrial fibrillation in humans. Circulation90, I-335 (1994) (Abstract).
  • Pappone C, Oreto G, Lamberti F et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation100, 1203–1208 (1999).
  • Pappone C, Oreto G, Rosanio S et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation104, 2539–2544 (2001).
  • Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation108, 2355–2360 (2003).
  • Nademanee K, McKenzie J, Kosar E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol.43, 2044–2053 (2004).
  • Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med.354, 934–941 (2006).
  • Ouyang F, Ernst S, Chun J et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double lasso catheter technique. Circulation112, 3038–3048 (2005).
  • Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol.42, 185–197 (2003).
  • Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA293, 2634–2640 (2005).
  • Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For the Cure of Atrial Fibrillation Study). Eur. Heart J.27, 216–221 (2006).
  • Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol.48, 2340–2347 (2006).
  • Jais P, Cauchemez B, Macle L et al. Atrial fibrillation ablation vs antiarrhythmic drugs: a multicenter randomized trial. Heart Rhythm3, 1126 (2006) (Abstract).
  • Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation112, 307–313 (2005).
  • Oral H, Chugh A, Ozaydin M et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation114, 759–765 (2006).
  • Weerasooriya R, Jais P, Le Heuzey JY et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing Clin. Electrophysiol.26, 292–294 (2003).
  • Chan PS, Vijan S, Morady F, Oral H. Cost–effectiveness of radiofrequency catheter ablation for atrial fibrillation. J. Am. Coll. Cardiol.47, 2513–2520 (2006).
  • Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation111, 1100–1105 (2005).
  • Pappone C, Oral H, Santinelli V et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation109, 2724–2726 (2004).
  • Good E, Oral H, Lemola K et al. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J. Am. Coll. Cardiol.46, 2107–2110 (2005).
  • Chugh A, Oral H, Lemola K et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm2, 464–471 (2005).
  • Chugh A, Oral H, Good E et al. Catheter ablation of atypical atrial flutter and atrial tachycardia within the coronary sinus after left atrial ablation for atrial fibrillation. J. Am. Coll. Cardiol.46, 83–91 (2005).
  • Ouyang F, Antz M, Ernst S et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double lasso technique. Circulation111, 127–135 (2005).
  • Cummings JE, Schweikert R, Saliba W et al. Left atrial flutter following pulmonary vein antrum isolation with radiofrequency energy: linear lesions or repeat isolation. J. Cardiovasc. Electrophysiol.16, 293–297 (2005).
  • Oral H, Chugh A, Good E et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation113, 1824–1831 (2006).
  • Knight BP, Oral H, Chugh A et al. Effects of operator experience on the outcome and duration of pulmonary vein isolation procedures for atrial fibrillation. Am. J. Cardiol.91, 673–677 (2003).
  • Pappone C, Vicedomini G, Manguso F et al. Robotic magnetic navigation for atrial fibrillation ablation. J. Am. Coll. Cardiol.47, 1390–1400 (2006).
  • Nakagawa H, Antz M, Wong T et al. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol.18, 136–144 (2007).
  • Marrouche NF, Martin DO, Wazni O et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation107, 2710–2716 (2003).
  • Jais P, Hocini M, Hsu LF et al. Technique and results of linear ablation at the mitral isthmus. Circulation110, 2996–3002 (2004).
  • Ouyang F, Bansch D, Ernst S et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation110, 2090–2096 (2004).
  • Hocini M, Jais P, Sanders P et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation112, 3688–3696 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.